The authors acknowledged that the study was limited and plan to follow the group through 4 years of treatment.
The findings suggest a neuroendocrine vulnerability in women with migraine.
The telephone-based treatment would allow for broader patient utilization.
Over 20% of women currently on HRT saw an increase in migraine severity.
Results suggest that lisdexamfetamine might help with concentration and thought organization.
The therapy did seem to improve symptoms of depression and anxiety in some women.
Neurology Advisor Articles
- 5 Key Findings Presented at 2018 Parkinson Disease Conference
- Parkinson Disease and the Gut: Treatment Potential Abounds
- Managing Comorbid Migraine and Mood Disorders: A Synergistic Approach
- Stroke-Code Patients With Low NIHSS Score, No Acute Imaging Findings Often Misdiagnosed
- Ethical Challenges of Nusinersen: Considerations When Counseling on Treatment
- Significant Variations in Epilepsy Surgical Strategy, Deficit Reporting Exist
- Smoking Promotes Disease Progression in Multiple Sclerosis
- Situation Framing, Language Can Influence Decision-Making
- Thrombolysis With Tenecteplase Is as Safe as Alteplase in Stroke Mimics
- FDA: Opioid Analgesic REMS Expanded to Include Immediate-Release Products